Chemotherapy-induced nausea and vomiting: From experimentation to expertise;Nausees et vomissements chimio-induits: De l'experimentation a l'experience

Bulletin du Cancer

Volumn 83, Issue 12, 1996, Pages 1014-1018

  Marty, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

5 HT3 receptor antagonists; chemotherapy induced emesis

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN ANTAGONIST; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; CANCER CHEMOTHERAPY; DOG; FERRET; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; VOMITING; ADOLESCENT; ADULT; AGED; ANIMAL; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; CHILD; DECISION MAKING; DRUG COMBINATION; FEMALE; HUMAN; IN VITRO STUDY; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; REVIEW; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DECISION MAKING; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NAUSEA; RISK ASSESSMENT; VOMITING;

EID: 0030321537     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Andrews PLR, Bhandari P, Garland S et al. Does retching have a function?: an experimental study in the ferret. Pharmacodyn Ther (Life Science Advances) 1990;9:135-52
2. Catimel G, Droz JP. Perspectives en chimiothérapie et répercussions sur la prise en charge de l'émésis. Bull Cancer 1995;82:1067-75
3. Clavel M. Les effets émétogènes des chimiothérapies anti-cancéreuses. Cah Cancer 1991;3:7-11
4. Costall B, Domeney AM, Naylor RJ et al. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs. Neuropharmacology 1987;9:1321-6
5. Fetting JH, Grochow LB, Folstein MF, Ettinger DS, Colvin M. The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 1982;66:1487-93
6. Groen HJM, Droz JP, Hanauske AR et al. A feasibility study with FCE 23762 every 4 weeks in adults with solid tumors. Proc Am Soc Clin Oncol 1995;14:468
7. Harris AL. Cytotoxic therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1992;i:714-6
8. Hawthorn J, Ostler KJ, Andrews PLR. The role of the abdominal visceral innervation and 5-hydroxytryptamine-M receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret. Q J Exp Physiol 1988;73:7-21
9. Kris MG. Gralla RJ. Clark RA et al. Incidence, course and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 1985;3:1379-84
10. Lindley CM, Bernard S, Fields SM. Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. J Clin Oncol 1989;7:1142-9
11. Martin M, Diaz-Rubio E, Sanchez A. Almenarez J. Lopez-Vega JM. The natural course of emesis after carboplatin treatment. Acta Oncol 1990;29:593-5
12. Martin Jimenez M, Diaz-Rubio E, Blasquez Encinar JC et al. Tolerancia, toxicidad y aceptation del tratamiento quimioterapico FAC (5-fluorouracilo, adriamicina y ciclofosfamida) en el cancer de mama. Analisis de 100 pacientes consecutivas. Neoplasia 1988;5:8-14
13. Martin M, Diaz-Rubio E. Emesis during post pregnancy: a new prognostic factor in chemotherapy-induced emesis. Ann Oncol 1990;1:152-3
14. Martin M. The severity and pattern of emesis following different cytotoxic agents. Oncology 1996;53 (Suppl 1):26-31
15. Marty M, Pouillart P, Scholl S et al. Comparison of the 5-hydroxytryptamine 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990;322:816-21
16. Marty M. Contrôle des nausées et vomissements chimio-induits en 1994 : approche globale dans la stratégie thérapeutique et apports de l'ondansétron. Cah Oncol 1994;3:289-92
17. Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 1985;55:2766-70
18. Naylor RJ, Rudd JA. Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology 1996;53 (Suppl 1):8-17
19. Richard A, Marty M. Étude des facteurs pronostiques des vomissements induits par les chimiothérapies anti-cancéreuses chez 2041 patients. Cah Oncol 1993;2:175-80
20. Rivière A, Beckendorf V, Bonneterre J et al. Standards, options et recommandations pour l'utilisation des antiémétiques en cancérologie. Bull Cancer 1995;82 (Suppl 4):453S-85S
21. 3 receptor antagonist GR38032F. Cancer Treat Rep 1987;14:333-6
22. Vermorken JB, Punt CJA, Eeltink CM et al. Phase 1 trial of carboplatin and amifostine (WR-2721) [Abstract 1010]. Proceedings of the 19th Congress of the European Society for Medical Oncology, November 18-22, 1994, Lisbon. Ann Oncol 1994;5 (Suppl 8):201